ProCE Banner Activity

Optimizing Therapy for Relapsed/Refractory Multiple Myeloma: Expert Answers to Your Questions

Podcast Episodes
In this podcast episode, listen to myeloma experts Suzanne Lentzsch, MD, PhD, and Saad Z. Usmani, MD, MBA, FACP, provide their thoughts on optimal treatment for relapsed/refractory multiple myeloma.

Released: June 17, 2021

Expiration: June 16, 2022

Share

Faculty

Suzanne Lentzsch

Suzanne Lentzsch, MD, PhD

Director, Multiple Myeloma and Amyloidosis Program
Associate Professor of Medicine
Division of Hematology/Oncology
Columbia University Medical Center
New York, New York

Saad Z. Usmani

Saad Z. Usmani, MD, MBA, FACP

Chief of Myeloma Service
Memorial Sloan Kettering Cancer Center
Professor
Weill Cornell Medical College, Cornell University
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Bristol Myers Squibb

Janssen administered by Scientific Affairs

Oncopeptides

Faculty Disclosure

Primary Author

Suzanne Lentzsch, MD, PhD

Director, Multiple Myeloma and Amyloidosis Program
Associate Professor of Medicine
Division of Hematology/Oncology
Columbia University Medical Center
New York, New York

Saad Z. Usmani, MD, MBA, FACP

Chief of Myeloma Service
Memorial Sloan Kettering Cancer Center
Professor
Weill Cornell Medical College, Cornell University
New York, New York